Labeling monocytes with gold nanoparticles to track their recruitment in atherosclerosis with computed tomography

Peter Chhour1, Pratap C Naha2, Sean M O'Neill3

  • 1Department of Radiology, University of Pennsylvania, 3400 Spruce St, 1 Silverstein, Philadelphia, PA 19104, USA; Department of Bioengineering, University of Pennsylvania, 3400 Spruce St, 1 Silverstein, Philadelphia, PA 19104, USA.

Biomaterials
|February 26, 2016
PubMed

Insights

Researchers tracked monocyte accumulation in atherosclerosis using gold nanoparticles and CT imaging. This method successfully visualized gold-labeled monocytes within plaques in mice, offering a new tool for non-invasive imaging.

Area of Science:

  • Biomedical Imaging
  • Nanotechnology
  • Cardiovascular Research

Background:

  • Monocyte recruitment into atherosclerotic plaques leads to foam cell formation and plaque rupture, a major cause of myocardial infarction.
  • Non-invasive imaging of coronary arteries using X-ray computed tomography (CT) is crucial for early detection and management.
  • Tracking monocyte accumulation within plaques is essential for understanding disease progression.

Purpose of the Study:

  • To develop and evaluate gold nanoparticles as contrast agents for CT imaging of monocyte accumulation in atherosclerosis.
  • To assess the safety and efficacy of gold nanoparticle-labeled monocytes in an animal model.
  • To demonstrate the feasibility of non-invasive CT imaging of monocyte trafficking in atherosclerotic plaques.

Main Methods:

  • Synthesis and characterization of gold nanoparticles stabilized with various ligands.
  • In vitro evaluation of nanoparticle formulations with monocyte cell lines for cytotoxicity, cytokine release, and cell uptake.
  • In vivo studies involving injection of gold-labeled primary monocytes into apolipoprotein E deficient mice and subsequent microCT imaging.
  • Biodistribution analysis and electron microscopy of plaque tissues.

Main Results:

  • 11-MUDA capped gold nanoparticles showed minimal cytotoxicity and high uptake by monocytes without affecting viability or cytokine release.
  • MicroCT imaging revealed a significant increase in aortic attenuation in mice receiving gold-labeled monocytes compared to controls.
  • Electron microscopy confirmed the presence of gold nanoparticles within monocytes inside atherosclerotic plaques.

Conclusions:

  • Gold nanoparticles are effective cell-labeling contrast agents for CT imaging.
  • This approach enables non-invasive tracking of monocyte accumulation in atherosclerotic plaques.
  • The study demonstrates the potential of this technique for diagnosing and monitoring cardiovascular disease.